Cargando…
A placebo-controlled randomized HPV16 synthetic long-peptide vaccination study in women with high-grade cervical squamous intraepithelial lesions
The aim of this study was to investigate the capacity of an HPV16 E6/E7 synthetic overlapping long-peptide vaccine to stimulate the HPV16-specific T-cell response, to enhance the infiltration of HPV16-specific type 1 T cells into the lesions of patients with HPV16+ high-grade cervical squamous intra...
Autores principales: | de Vos van Steenwijk, Peggy J., Ramwadhdoebe, Tamara H., Löwik, Margriet J. G., van der Minne, Caroline E., Berends-van der Meer, Dorien M. A., Fathers, Lorraine M., Valentijn, A. Rob P. M., Oostendorp, Jaap, Fleuren, Gert Jan, Hellebrekers, Bart W. J., Welters, Marij J. P., van Poelgeest, Mariette I., Melief, Cornelis J. M., Kenter, Gemma G., van der Burg, Sjoerd H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer-Verlag
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3427705/ https://www.ncbi.nlm.nih.gov/pubmed/22684521 http://dx.doi.org/10.1007/s00262-012-1292-7 |
Ejemplares similares
-
HPV16 synthetic long peptide (HPV16-SLP) vaccination therapy of patients with advanced or recurrent HPV16-induced gynecological carcinoma, a phase II trial
por: van Poelgeest, Mariette I E, et al.
Publicado: (2013) -
Pre-existing inflammatory immune microenvironment predicts the clinical response of vulvar high-grade squamous intraepithelial lesions to therapeutic HPV16 vaccination
por: Abdulrahman, Ziena, et al.
Publicado: (2020) -
A pre‐existing coordinated inflammatory microenvironment is associated with complete response of vulvar high‐grade squamous intraepithelial lesions to different forms of immunotherapy
por: Abdulrahman, Ziena, et al.
Publicado: (2020) -
Synergy of therapeutic vaccination against HPV16 oncogenic proteins and standard chemotherapeutics
por: Melief, Cornelis J, et al.
Publicado: (2014) -
Potential use of lymph node-derived HPV-specific T cells for adoptive cell therapy of cervical cancer
por: van Poelgeest, Mariëtte I. E., et al.
Publicado: (2016)